Filed: 8/9/2023ACC: 0000950123-23-007098
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $84.30M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$84.30M
Total AUM (reported)
21.27M
Total Shares
Allocation by class
COMMON STOCK$56.31M66.8%
COMMON SHARES$27.99M33.2%
Portfolio Concentration
Top 3$64.05M76.0%
4–10$20.25M24.0%
Top 3 weight
76.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.27M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
21.27M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$28.00M
33.22%
Sole
0.00
Shared
2.65M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$27.99M
33.20%
Sole
0.00
Shared
498.56K
None
0.00
Adverum Biotechnologies, Inc.
OTRShares5.07M
TypeSH
Market value$8.06M
9.56%
Sole
0.00
Shared
5.07M
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$6.94M
8.24%
Sole
0.00
Shared
3.56M
None
0.00
CymaBay Therapeutics, Inc.
OTRShares543.75K
TypeSH
Market value$5.95M
7.06%
Sole
0.00
Shared
543.75K
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$4.67M
5.54%
Sole
0.00
Shared
4.96M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$2.25M
2.67%
Sole
0.00
Shared
2.32M
None
0.00
Minerva Surgical Inc.
OTRShares1.67M
TypeSH
Market value$428.8K
0.51%
Sole
0.00
Shared
1.67M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $28.00M 33.22% | 0.00 | 2.65M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $27.99M 33.20% | 0.00 | 498.56K | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 5.07M | SH | $8.06M 9.56% | 0.00 | 5.07M | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $6.94M 8.24% | 0.00 | 3.56M | 0.00 |
CymaBay Therapeutics, Inc.OTR | Common Stock | 543.75K | SH | $5.95M 7.06% | 0.00 | 543.75K | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $4.67M 5.54% | 0.00 | 4.96M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $2.25M 2.67% | 0.00 | 2.32M | 0.00 |
Minerva Surgical Inc.OTR | Common Stock | 1.67M | SH | $428.8K 0.51% | 0.00 | 1.67M | 0.00 |